DE60336353D1 - Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung - Google Patents
Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendungInfo
- Publication number
- DE60336353D1 DE60336353D1 DE60336353T DE60336353T DE60336353D1 DE 60336353 D1 DE60336353 D1 DE 60336353D1 DE 60336353 T DE60336353 T DE 60336353T DE 60336353 T DE60336353 T DE 60336353T DE 60336353 D1 DE60336353 D1 DE 60336353D1
- Authority
- DE
- Germany
- Prior art keywords
- seq
- amino acid
- recombinant protein
- protein
- same activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 7
- 230000000694 effects Effects 0.000 title abstract 5
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- 230000001093 anti-cancer Effects 0.000 abstract 2
- 238000007792 addition Methods 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2003/000928 WO2005042744A1 (en) | 2003-11-03 | 2003-11-03 | A recombinant protein with cancer suppression action, its encoding gene and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60336353D1 true DE60336353D1 (de) | 2011-04-21 |
Family
ID=34529378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60336353T Expired - Lifetime DE60336353D1 (de) | 2003-11-03 | 2003-11-03 | Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7666989B2 (enExample) |
| EP (1) | EP1688498B1 (enExample) |
| JP (1) | JP4688678B2 (enExample) |
| CN (1) | CN100549175C (enExample) |
| AT (1) | ATE501256T1 (enExample) |
| AU (1) | AU2003280921B2 (enExample) |
| BR (1) | BRPI0318594B8 (enExample) |
| CA (1) | CA2544473C (enExample) |
| DE (1) | DE60336353D1 (enExample) |
| NZ (1) | NZ547274A (enExample) |
| WO (1) | WO2005042744A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003292696A1 (en) | 2002-12-26 | 2004-08-10 | Takeda Pharmaceutical Company Limited | Metastin derivative and use thereof |
| CN101845091A (zh) | 2004-06-25 | 2010-09-29 | 武田药品工业株式会社 | 转移素衍生物及其用途 |
| TWI386417B (zh) | 2005-12-22 | 2013-02-21 | Takeda Pharmaceutical | 轉移抑素衍生物及其用途 |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| JO3048B1 (ar) | 2006-10-25 | 2016-09-05 | Takeda Pharmaceuticals Co | مشتقات متاستين واستخدامها |
| WO2009131191A1 (ja) * | 2008-04-24 | 2009-10-29 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
| RS54057B1 (sr) | 2010-12-03 | 2015-10-30 | Adamed Sp. Zo.O. | Antikancerski fuzioni protein |
| PL219845B1 (pl) | 2011-01-05 | 2015-07-31 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
| PL394618A1 (pl) | 2011-04-19 | 2012-10-22 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
| EP2752429B1 (en) | 2011-09-16 | 2017-03-01 | Beijing Sunbio Biotech Co. Ltd. | Fusion protein comprising circularly permuted form of trail/apo2l, coding gene and use thereof |
| PL397167A1 (pl) | 2011-11-28 | 2013-06-10 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Przeciwnowotworowe bialko fuzyjne |
| PL223487B1 (pl) | 2011-12-28 | 2016-10-31 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Przeciwnowotworowe białko fuzyjne |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2253753T3 (es) * | 1995-06-29 | 2006-06-01 | Immunex Corporation | Citocina que induce apoptosis. |
| US6284236B1 (en) * | 1995-06-29 | 2001-09-04 | Immunex Corporation | Cytokine that induces apoptosis |
| KR20010019100A (ko) * | 1999-08-25 | 2001-03-15 | 황규언 | 인간 유래 세포소멸인자 ｔｒａｉｌ의 결정화에 의한 3차원 구조 |
| US6900185B1 (en) * | 2000-04-12 | 2005-05-31 | University Of Iowa Research Foundation | Method of inducing tumor cell apoptosis using trail/Apo-2 ligand gene transfer |
| KR100436089B1 (ko) * | 2000-07-06 | 2004-06-14 | 설대우 | 분비성 재조합 트라이머형의 트레일 단백질 생산을 위한 디엔에이 카세트, 테트라사이클린/독시사이클린-유도성아데노-관련 바이러스 벡터, 이 둘의 조합, 및 이들을이용한 유전자 치료 |
| CN1205335C (zh) * | 2001-11-30 | 2005-06-08 | 中国人民解放军第二军医大学 | 肿瘤凋亡诱导配体基因、基因表达蛋白及其制备方法 |
-
2003
- 2003-11-03 JP JP2005510086A patent/JP4688678B2/ja not_active Expired - Lifetime
- 2003-11-03 NZ NZ547274A patent/NZ547274A/en not_active IP Right Cessation
- 2003-11-03 US US10/577,535 patent/US7666989B2/en not_active Expired - Lifetime
- 2003-11-03 CN CNB2003801106041A patent/CN100549175C/zh not_active Expired - Lifetime
- 2003-11-03 AT AT03770858T patent/ATE501256T1/de not_active IP Right Cessation
- 2003-11-03 EP EP03770858A patent/EP1688498B1/en not_active Expired - Lifetime
- 2003-11-03 AU AU2003280921A patent/AU2003280921B2/en not_active Expired
- 2003-11-03 CA CA2544473A patent/CA2544473C/en not_active Expired - Lifetime
- 2003-11-03 BR BRPI0318594A patent/BRPI0318594B8/pt not_active IP Right Cessation
- 2003-11-03 DE DE60336353T patent/DE60336353D1/de not_active Expired - Lifetime
- 2003-11-03 WO PCT/CN2003/000928 patent/WO2005042744A1/zh not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2544473A1 (en) | 2005-05-12 |
| HK1089788A1 (zh) | 2006-12-08 |
| JP2007536891A (ja) | 2007-12-20 |
| CN1860229A (zh) | 2006-11-08 |
| BR0318594A (pt) | 2006-10-17 |
| US7666989B2 (en) | 2010-02-23 |
| NZ547274A (en) | 2009-02-28 |
| ATE501256T1 (de) | 2011-03-15 |
| BRPI0318594B1 (pt) | 2017-12-26 |
| AU2003280921B2 (en) | 2007-09-13 |
| CN100549175C (zh) | 2009-10-14 |
| US20080280821A1 (en) | 2008-11-13 |
| EP1688498A1 (en) | 2006-08-09 |
| JP4688678B2 (ja) | 2011-05-25 |
| CA2544473C (en) | 2013-08-13 |
| EP1688498B1 (en) | 2011-03-09 |
| BRPI0318594B8 (pt) | 2021-05-25 |
| AU2003280921A1 (en) | 2005-05-19 |
| EP1688498A4 (en) | 2007-06-20 |
| WO2005042744A1 (en) | 2005-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60327786D1 (de) | Kdr-peptide und diese enthaltende impfstoffe | |
| WO2010135491A3 (en) | Fibroblast growth factor mutants having improved functional half-life and methods of their use | |
| ATE501256T1 (de) | Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung | |
| ATE417595T1 (de) | Keratin-bindende polypeptide | |
| ATE454403T1 (de) | Menschliche koagulationsfaktor vii polypeptide | |
| ATE476507T1 (de) | Transkriptionsfaktor aus arabidopis thaliana sowie codierendes gen und verwendung davon | |
| DE60138558D1 (de) | Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung | |
| JP2004505640A5 (enExample) | ||
| ATE551353T1 (de) | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten | |
| JP2007536891A5 (enExample) | ||
| RU2006119452A (ru) | Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение | |
| JP2003334088A5 (enExample) | ||
| CA2422295A1 (en) | A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene | |
| WO2002034882A3 (en) | Genes regulating programmed cell death | |
| DE602005025989D1 (de) | Von 2',3'-didesoxynucleosiden und 2',3'-didehydro-2',3'-didesoxynucleosiden | |
| GB2441941A (en) | An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide | |
| DE50211988D1 (de) | Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren | |
| CA2498651A1 (en) | Nucleoside triphosphate diphosphohydrolase and uses thereof | |
| WO2009069546A1 (ja) | 代謝症候群の治療もしくは予防剤、検査方法、検査薬、及び代謝症候群の治療薬の候補化合物のスクリーニング方法 | |
| SG170757A1 (en) | Polypeptide having esterase activity and recombinant esterase and use thereof | |
| DE602004019556D1 (de) | Neues plexin-polypeptid, dieses codierende dna und verwendung davon | |
| ATE414155T1 (de) | Moraxella (branhamella) catarrhalis polypeptide | |
| ATE286535T1 (de) | Regulatorisches protein pke 83 aus humanen keratinozyten | |
| RU2008130819A (ru) | Способ продукции рекомбинантной стафилокиназы при регулировании уровня кислорода | |
| DE602007009797D1 (de) | Antitumorheilmittel, Medikament, Zusammensetzung und Verwendung davon |